ABCL
AbCellera BiologicsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
ABCL vs peer average
61/100
ABCL vs. peer average (C vs. D)
Grade spread
B 1 · C 2 · D 5 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
IMCR is the first available peer comparator.
Immunocore is a closer clinical-stage biotech comp where valuation is still heavily milestone-driven, although modality and commercial maturity differ, so read-through for ABCL remains limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ABCL
AbCellera Biologics
IMCR
Immunocore American
Grade
C
D
Momentum
92
58
Value
41
41
Sentiment
36
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs IMCR
ABCL / IMCR
Grade Position
In line
ABCL vs. peer average (C vs. D)
61/100
Momentum
92
ABCLValue
41
ABCLSentiment
36
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ABCL
IMCR is the first peer returned for this comparison set.